Evidence map›Paper›PMID 41437226›Full record

ArticleBMC ophthalmology2025

Evaluation of systemic inflammatory biomarkers associated with high-density lipoprotein in keratoconus patients: a retrospective case-control study.

Burçin Çakır, Muhammed Muaz Osmanoğlu, Büşra Güner Sönmezoğlu

Abstract read
In one paragraph

Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Burçin ÇakırDepartment of Ophthalmology, Sakarya Training and Research Hospital, Sakarya, Turkey. burcincakir@sakarya.edu.tr.
Muhammed Muaz OsmanoğluDepartment of Ophthalmology, Sakarya Training and Research Hospital, Sakarya, Turkey.
Büşra Güner SönmezoğluDepartment of Ophthalmology, Serdivan State Hospital, Sakarya, Turkey. busra-gnr1@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo evaluate systemic inflammatory markers including the monocyte to high density lipoprotein cholesterol (HDL) ratio (MHR), neutrophil to HDL ratio (NHR), lymphocyte to HDL ratio (LHR), neutrophil to lymphocyte ratio (NLR), platelet to HDL ratio (PHR) in patients with keratoconus (KC). Correlations between these systemic markers and corneal topographic parameters were also investigated.

methodsRetrospective analysis of peripheral blood sample results in patients with KC (n: 103) were performed. Mean MHR, NHR, LHR, NLR, and PHR were calculated in KC patients, and age and sex matched healthy controls (n:99). Corneal topography markers were also evaluated and correlations with systemic inflammatory markers were investigated.

resultsThe mean PHR was significantly higher in KC group compared to control group (p = 0.004). Optimal PHR cut-off value for KC was calculated as 4807 with 74.8% sensitivity and 45.5% specificity. No significant correlation was found between corneal topograhy parameters and systemic inflammatory markers.

conclusionsThe mean PHR value was found to be higher in patients with keratoconus and no correlation was found between corneal topography findings and systemic inflammatory markers. This study is the first to explore HDL associated systemic inflammatory markers.

Indexed as

BiomarkersCholesterol, HDLInflammationKeratoconusLipoproteins, HDLAdolescentAdultCase-Control StudiesCorneal TopographyFemaleHumansLymphocytesMaleMiddle AgedNeutrophilsRetrospective StudiesBiomarkersCholesterol, HDLLipoproteins, HDLHigh density lipoproteinPlateletProgressive keratoconusSystemic inflammation

Identifiers

PMID41437226
PMCPMC12729630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.